Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-11-22

Clinical Trial Update: Estrogen and the Urogenital Microbiome in GSM [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating on estrogen effects and the urogenital microbiome in menopause.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Oregon Health and Science University | Conditions: Menopause | Phase 4 | Status: COMPLETED